Tag: Hepatitis C | CATIE Blog

Busting common myths about hepatitis C treatment in Canada

March 19, 2024 • By Sofia Bartlett

Highly effective medications that can cure hepatitis C infection, called direct-acting antivirals (DAAs), have been approved for use in Canada for people over the age of 18 since 2014. These medications are well-tolerated, nearly 100% effective, and have treatment durations of just eight or 12 weeks. DAAs have simplified hepatitis C treatment considerably, allowing treatments to be prescribed by primary care providers, such as nurse practitioners and family doctors. Now that the treatment itself is so simple, getting coverage for reimbursement of DAAs is the most complicated and challenging aspect of treating hepatitis C infection in Canada. Almost 90% of...

INHSU 2023: Global lessons for the health of people who use drugs

November 10, 2023 • By Christopher Hoy

In October, CATIE attended INHSU 2023, the 11th International Conference on Health and Hepatitis Care in Substance Users. This leading international conference brought experts from around the world to Geneva, Switzerland, where they discussed the latest in research, programs and policy on hepatitis and the health of people who use drugs. While there, CATIE spoke with presenters and attendees and asked them to share key messages from the conference. Watch the short videos below and catch up on some of the topics discussed at INHSU 2023. Christopher Hoy is the associate director of Ontario hepatitis C and harm reduction...

Visual voice: Incorporating story with wellness

August 15, 2023 • By Kate Dunn

“We know the hepatitis C virus is a silent, often sneaky virus that wreaks havoc in the liver, is detectable through screening and is cured through oral medication in a matter of weeks. But our rates are rising because there is no personal engagement. We need culturally connected awareness resources to make an impact.” -Indigenous Knowledge Keeper While collaborating with an Indigenous community in Alberta to streamline hepatitis C pathways to care, I had the opportunity to take part in the co-creation of a culturally connected liver health awareness film. I was inspired to action when this resource was...

The Waniska Gathering

July 31, 2023 • By Alexandra King and Saydi Harlton

On June 6 and 7, 2023, an empowering event took place on Treaty 6 and Homeland of the Métis at Wanuskewin, a sacred site and gathering place located in what has become known as Saskatoon. It left a lasting impact on participants and nurtured hope for Indigenous health. The Waniska Gathering was a two-day event addressing crucial issues such as Indigenous health, HIV, hepatitis C and other sexually transmitted and blood-borne infections (STBBI). It was organized by Waniska, an Indigenous-led research centre focused on Saskatchewan and Manitoba. Before the event started, an opening feast was held with community and guests....

Treating hepatitis C in children: How does it work?

July 4, 2023 • By Dr. Fernando Alvarez

Did you know that hepatitis C is a liver infection that can be cured within eight to 12 weeks thanks to treatments that are nearly 100% effective? Called direct-acting antivirals, these treatments were first designed for people over the age of 18, but treatment options for people under the age of 18 have also been developed in recent years. This includes a treatment approved in Canada for children aged three years and older, which is a game changer in the pediatric context. Romane Close, CATIE’s specialist for resource development and knowledge mobilization, had the chance to speak with Dr. Fernando Alvarez,...

New Canadian hepatitis C estimates tell us how far we’ve come (and how far we have to go)

July 4, 2023 • By Melisa Dickie and Shannon Elliot

Canada has joined countries around the world in committing to eliminate hepatitis C as a public health threat by 2030. However, how do we know if we’re on track to reach that goal and how do we measure our progress along the way? Fortunately, the World Health Organization established targets in its Global Health Sector Strategy on Viral Hepatitis, which have been adapted to the Canadian context by the Public Health Agency of Canada (PHAC). These targets lay out a path to elimination with concrete objectives, that include a 90% reduction in new hepatitis C infections by 2030, as...